Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-08

Clinical Trial Update: Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

View source ↗

Summary

A clinical trial update reports on how titration, analgesics, and BET A nurse support influence acceptance rates for Betaseron treatment in patients with early …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaseron (Interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting | Status: COMPLETED